Lamin B1 Antibody (ZL-5) Summary
| Immunogen |
Recombinant human Lamin B.
|
| Marker |
Nuclear Envelope Marker
|
| Specificity |
The antibody recognizes the 68 kDa lamin B1 isoform. Reactivity with other lamin isoforms has not been detected.
|
| Isotype |
IgG1 Kappa
|
| Clonality |
Monoclonal
|
| Host |
Rabbit
|
| Gene |
LMNB1
|
| Purity |
Protein A or G purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
| Application Notes |
Western blotting (0.5-2 ug/ml), immunoprecipitation (5 ug/ml), immuno-fluorescence (10-15 ug/ml), and ELISA (0.2-1 ug/ml). However, the optimal conditions should be determined individually.
|
Packaging, Storage & Formulations
| Storage |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
|
| Buffer |
PBS, 1.0% BSA, and 50% Glycerol
|
| Preservative |
15mM Sodium Azide
|
| Concentration |
0.2 mg/ml
|
| Purity |
Protein A or G purified
|
Alternate Names for Lamin B1 Antibody (ZL-5)
- ADLD
- Lamin B1
- lamin-B1
- LMN
- LMN2
- LMNB
- LMNB1
- MGC111419
Background
The lamins form a meshwork of filaments on the inner, or nucleoplasmic, surface of the nuclear envelope. Currently, mammalian species appear to contain at least four major lamins, called A, B1, B2, and C, of which two (A and C) arise by alternative splicing of the same gene and two minor lamins, D and E, whose molecular weight varies from species to species. Nuclei of embryonic and lymphiod cells contain only lamin B1. Mutations affecting A-type lamins have been associated with a variety of human diseases, including muscular dystrophy, cardiomyopathy, lipodystrophy, and progeria, but mutations in B-type lamins have never been identified in humans. Homozygous lamin B1 mutant mice survive embryonic development but died at birth with defects in lung and bone. Cells obtained from mutant lamin B1 mice are defective in differentiation, polyploidy and senesce prematurely.